Variant report
Variant | esv3410793 |
---|---|
Chromosome Location | chr13:63261251-63263799 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527508518 | chr13:63263039-63263040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530169011 | chr13:63263045-63263046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189816628 | chr13:63263056-63263057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376786660 | chr13:63263107-63263108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200450914 | chr13:63263108-63263109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140468358 | chr13:63263109-63263110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116778831 | chr13:63263110-63263111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114475342 | chr13:63263112-63263113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181837998 | chr13:63263118-63263119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551078954 | chr13:63263127-63263128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569188810 | chr13:63263154-63263155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs59198117 | chr13:63263157-63263158 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs546680471 | chr13:63263226-63263227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185065079 | chr13:63263246-63263247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555565050 | chr13:63263261-63263262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs566800392 | chr13:63263262-63263263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534127314 | chr13:63263307-63263308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558770901 | chr13:63263309-63263310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577010884 | chr13:63263315-63263316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543934145 | chr13:63263333-63263334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574002399 | chr13:63263388-63263389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574371476 | chr13:63263426-63263427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541773830 | chr13:63263432-63263433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560195974 | chr13:63263437-63263438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189396793 | chr13:63263445-63263446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs180966177 | chr13:63263455-63263456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564307199 | chr13:63263469-63263470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531515033 | chr13:63263471-63263472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113387411 | chr13:63263515-63263516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71098966 | chr13:63263516-63263517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551119666 | chr13:63263523-63263524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74085307 | chr13:63263598-63263599 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs530051751 | chr13:63263609-63263610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570812364 | chr13:63263634-63263635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185197652 | chr13:63263734-63263735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 21346763 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63263000-63265000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr13:63263200-63264400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr13:63263200-63266000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr13:63263400-63264000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr13:63263600-63264400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr13:63263600-63265200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |